Effect of Postmenopausal Hormone Therapy on Glucose and Insulin Concentrations

Abstract

Oral hormone therapy involving 0.625 mg/day of CEE may modestly decrease fasting levels of insulin and glucose. Postchallenge glucose concentrations are increased, however, which may indicate delayed glucose clearance.